Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study (Q36621905)
Jump to navigation
Jump to search
scientific article published on 29 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study |
scientific article published on 29 January 2013 |
Statements
1 reference
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study (English)
1 reference
Richard Webby
1 reference
Marc Gurwith
1 reference
Michael Lock
1 reference
Eve M Taylor
1 reference
Glenn Ishioka
1 reference
Jeff Alexander
1 reference
Tim Mayall
1 reference
John E Ervin
1 reference
Richard N Greenberg
1 reference
Cynthia Strout
1 reference
John J Treanor
1 reference
Peter F Wright
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference